Live Breaking News & Updates on Richard Casaburi

Stay updated with breaking news from Richard casaburi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Non-prescription portable oxygen concentrators may not be 'clinically useful'

For patients who need ambulatory oxygen, over-the-counter portable oxygen concentrators sold online that do not require a prescription may not be helpful, according to study results published in Respiratory Care.“My colleagues at the COPD Foundation and I were concerned that patients with COPD who require ambulatory oxygen might purchase OTC (not requiring a prescription) oxygen ....

Richardd Branson , Richard Casaburi , University Of Cincinnati College Medicine , David Geffen School Of Medicine , David Geffen School , Cincinnati College ,

FDA Approval Of Tudorza Pressair For Long-term Treatment Of COPD


Almirall, S.A. (ALM.MC) and Forest Laboratories, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved Tudorza(TM) Pressair(TM) (aclidinium bromide inhalation powder) for the long-term maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. 
COPD is a common, progressive, and debilitating lung disease characterized by persistent airflow limitation that makes it hard to breathe; it is currently the third leading cause of mortality in the US. Characteristic symptoms include breathlessness, excessive production of sputum, and a chronic cough.
Tudorza(TM) is a twice-daily inhaled long-acting anticholinergic, also referred to as a long-acting muscarinic antagonist (LAMA). Tudorza(TM) produces bronchodilation by inhibiting acetylcholine s effect on muscarinic receptors in the airway smooth muscle. Forest expects Tudorza(TM) Pressair(TM) to be available to wholesaler ....

Howard Solomon , Tudorza Pressair , Jorge Gallardo , Richard Casaburi , Forest Laboratories Inc , Global Initiative For Chronic Obstructive Lung Disease , Drug Administration , Forest Laboratories , Chief Executive Officer , Associate Chief , Critical Care Physiology , Global Initiative , Chronic Obstructive Lung Disease , ஹோவர்ட் சாலமன் , ஜார்ஜ் கால்டொ , காடு ஆய்வகங்கள் இன்க் , உலகளாவிய முயற்சி க்கு நாள்பட்ட தடைசெய்யும் நுரையீரல் நோய் , காடு ஆய்வகங்கள் , தலைமை நிர்வாகி அதிகாரி , இணை தலைமை , முக்கியமான பராமரிப்பு உடலியல் , உலகளாவிய முயற்சி , நாள்பட்ட தடைசெய்யும் நுரையீரல் நோய் ,